Format

Send to

Choose Destination
NMC Case Rep J. 2019 Sep 11;6(4):111-115. doi: 10.2176/nmccrj.cr.2018-0300. eCollection 2019 Oct.

Intracavernous Hemangiopericytoma: Case Report and Review of the Literature.

Author information

1
Department of Neurosurgery, Osaka City General Hospital, Osaka, Osaka, Japan.

Abstract

Intracavernous hemangiopericytoma/solitary fibrous tumor is an extremely rare tumor, with only seven cases reported. We present a case of intracavernous hemangiopericytoma/solitary fibrous tumor and review all cases reported in the literature. A 67-year-old man experienced numbness over the left half of the face. Magnetic resonance imaging revealed a left intracavernous tumor extending into Meckel's cave and the posterior fossa. We performed gamma knife surgery (GKS) which a prescribed dose to the tumor of 12 Gy, but tumor recurred 43 months after GKS. We performed partial tumor resection via a subtemporal interdural approach. The pathological diagnosis was hemangiopericytoma. Postoperatively, we performed second GKS with a prescribed dose of 15 Gy. Diplopia and ptosis improved markedly and the tumor initially reduced in size, but tumor regrowth was seen again 29 months after second GKS. Third GKS was performed with a prescribed dose of 15 Gy. Recurrence was not seen at 18 months after third GKS, but was identified about 2 years after third GKS. We performed fourth GKS with a prescribed dose to the residual tumor of 16 Gy. We report a rare case of intracavernous hemangiopericytoma originating in the cavernous sinus, but distinguishing between hemangiopericytoma and schwannoma is difficult for round, intracavernous tumors showing homogeneous enhancement without flow voids. GKS might be one of the options for residual and recurrent intracavernous hemangiopericytomas.

KEYWORDS:

cavernous sinus; gamma knife surgery; hemangiopericytoma

Conflict of interest statement

Conflicts of Interest Disclosure This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. None of authors have no conflicts of interest.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center